MGNX MacroGenics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 14, 2026
$3,58
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,29mínimo 52 semanas
$5,08máximo 52 semanas
Capitalización Bursátil (MRQ)
$228M
P/E (TTM)
-15.6
BPA (TTM)
$-0.23
Ingresos (TTM)
$168M
tus insignias
Rango 52S
$1–$5
Calificación del Analista
BUY
Precio Objetivo
$8
P/E
-15.6
ROE
-32.6%
Margen de Beneficio Neto
-8.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
MGNX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.58
Capitalización Bursátil (MRQ)
$228M
P/E (TTM)
-15.6
BPA (TTM)
$-0.23
Ingresos (TTM)
$168M
ROE (TTM)
-32.6%
Rango 52S
$1–$5
MGNX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$150M2016-12-31 → 2025-12-31
BPA$-1.182020-12-31 → 2025-12-31
Flujo de caja libre$-83M2016-12-31 → 2025-12-31
Margen neto-8.7%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | MGNX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -15.6promedio 5A ≈-15.3 | ≈-15.3 | · | · | |
| P/S (TTM) | 1.4promedio 5A ≈5.5 | ≈5.5 | 29.5 | Infravalorado | |
| P/C (MRQ) | 5.3promedio 5A ≈2.9 | ≈2.9 | 4.9 | Más caro | |
| Precio / FCF (TTM) | -3.5promedio 5A ≈-4.5 | ≈-4.5 | · | · | |
| Precio / Flujo de Caja (TTM) | -3.6promedio 5A ≈-4.7 | ≈-4.7 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 4.1promedio 5A ≈2.9 | ≈2.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | MGNX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -24.3%promedio 5A ≈-150.1% | ≈-150.1% | -680.6% | De primer nivel | |
| Margen EBITDA (TTM) | -20.8%promedio 5A ≈-140.4% | ≈-140.4% | -664.4% | De primer nivel | |
| Pretax Margin (Margen antes de impuestos) | -50.4% | · | · | · | |
| Margen de Beneficio Neto (TTM) | -8.7%promedio 5A ≈-90.0% | ≈-90.0% | -1229.7% | De primer nivel | |
| ROA (TTM) | -4.9%promedio 5A ≈-30.3% | ≈-30.3% | -29.4% | En línea | |
| ROE (TTM) | -32.6%promedio 5A ≈-56.2% | ≈-56.2% | -41.9% | Débil | |
| ROIC | -129.9% | · | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | MGNX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 3.0promedio 5A ≈4.4 | ≈4.4 | 5.4 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 1.6promedio 5A ≈2.4 | ≈2.4 | 4.6 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | MGNX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -0.31%promedio 5A ≈32.7% | ≈32.7% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -0.54%promedio 5A ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 7.3% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | MGNX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.6promedio 5A ≈0.4 | ≈0.4 | 0.1 | De primer nivel | |
| Inventory Turnover (Rotación de Inventario) | 0.0promedio 5A ≈0.8 | ≈0.8 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 16.9promedio 5A ≈9.7 | ≈9.7 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$510.2K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
16.8%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 13, 2026 | $-0.26 | $-0.13 | -102.7% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.58 | $-0.58 | 0.45% |
| 31 de diciembre de 2025 | $-0.23 | $-0.30 | 22.4% | |
| 30 de septiembre de 2025 | $0.27 | $-0.50 | 153.8% | |
| 30 de junio de 2025 | $-0.57 | $-0.62 | 8.1% | |
| 31 de marzo de 2025 | $-0.65 | $-0.80 | 18.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $150M | $150M | $59M | $152M | $77M | $105M | $64M | $60M | $158M | $92M | $101M | $48M | |
| Cost of Revenue | $0 | $847.0K | $619.0K | $3M | $3M | $0 | $0 | · | · | · | · | · | |
| R&D Expense | $147M | $177M | $167M | $207M | $215M | $193M | $195M | $191M | $147M | $122M | $98M | $70M | |
| SG&A Expense | $39M | $71M | $52M | $59M | $63M | $43M | $46M | $40M | $33M | $30M | $23M | $16M | |
| Operating Expenses | $222M | $261M | $227M | $273M | $280M | $236M | $241M | $231M | $180M | $152M | $121M | $86M | |
| Operating Income | $-73M | $-111M | $-168M | $-121M | $-203M | $-131M | $-177M | $-171M | $-22M | $-60M | $-20M | $-38M | |
| Interest Expense | · | $1M | $1M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-op | $6M | $9M | $10M | $2M | $680.0K | $1M | $25M | $-247.0K | $3M | $2M | $42.0K | $2.0K | |
| Pretax Income | $-75M | $-66M | $-9M | $-120M | · | · | · | · | · | · | · | · | |
| Income Tax | $-672.0K | $944.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-75M | $-67M | $-9M | $-120M | $-202M | $-130M | $-152M | $-171M | $-20M | $-59M | $-20M | $-38M | |
| EPS (Basic) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | · | · | · | · | · | $-1.40 | |
| EPS (Diluted) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | · | · | · | · | · | $-1.40 | |
| Shares (Basic) | 63,155,096 | 62,621,185 | 61,929,198 | 61,433,124 | 59,944,717 | 52,442,389 | 48,082,728 | · | 36,095,080 | 34,685,274 | 31,801,645 | 27,384,990 | |
| Shares (Diluted) | 63,155,096 | 62,621,185 | 61,929,198 | 61,433,124 | 59,944,717 | 52,442,389 | 48,082,728 | · | 36,095,080 | 34,685,274 | 31,801,645 | 27,384,990 | |
| EBITDA | $-66M | $-103M | $-159M | $-110M | $-192M | $-119M | · | $-163M | $-15M | $-52M | $-17M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $183M | $101M | $109M | $123M | $181M | $126M | $220M | $212M | $84M | $196M | $158M | |
| Short-term Investments | · | · | · | · | · | · | $89M | $13M | $93M | $193M | $143M | · | |
| Receivables | $427.0K | $4M | $10M | $56M | $10M | $23M | $13M | $30M | $14M | $3M | $1M | $3M | |
| Inventory | $8M | $0 | $1M | $1M | $4M | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $12M | $10M | $10M | $21M | $17M | $11M | $7M | $3M | $3M | $2M | $4M | |
| Current Assets | $220M | $217M | $251M | $222M | $280M | $313M | $240M | $269M | $322M | $284M | $342M | $165M | |
| PP&E (Net) | $2M | $18M | $22M | $30M | $38M | $42M | $48M | $57M | $50M | $18M | $15M | $7M | |
| PP&E (Gross) | $108M | $107M | $110M | $114M | $110M | $104M | $98M | $95M | $79M | $44M | $35M | $24M | |
| Accum. Depreciation | $96M | $89M | $88M | $84M | $73M | $62M | $50M | $38M | $29M | $26M | $20M | $17M | |
| Other Non-current Assets | $207.0K | $2M | $1M | $1M | $1M | $24M | $25M | $6M | $2M | $1M | $2M | $2M | |
| Total Assets | $257M | $262M | $298M | $280M | $335M | $379M | $313M | $332M | $374M | $311M | $359M | $174M | |
| Accounts Payable | $3M | $5M | $6M | $5M | $16M | $8M | $4M | $4M | $2M | $4M | $3M | $2M | |
| Accrued Liabilities | $22M | $29M | $24M | $29M | $34M | $34M | $27M | $33M | $39M | $16M | $12M | $8M | |
| Current Liabilities | $43M | $56M | $56M | $49M | $75M | $51M | $45M | $60M | $50M | $27M | $24M | $27M | |
| Capital Leases | $31M | $33M | $30M | $30M | $21M | $25M | $28M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $1M | $2M | $258.0K | $258.0K | $258.0K | $0 | $0 | · | · | · | $0 | · | |
| Total Liabilities | $201M | $146M | $146M | $138M | $96M | $83M | $82M | $89M | $75M | $43M | $46M | $53M | |
| Common Stock | $633.0K | $628.0K | $621.0K | $617.0K | $613.0K | $562.0K | $490.0K | $424.0K | $369.0K | $349.0K | $343.0K | $280.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $335M | |
| Retained Earnings | $-1.24B | $-1.17B | $-1.10B | $-1.09B | $-974M | $-772M | $-642M | $-490M | $-312M | $-293M | $-234M | $-214M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $0 | $19.0K | |
| Stockholders' Equity | $56M | $116M | $153M | $142M | $240M | $296M | $231M | $243M | $299M | $269M | $313M | $121M | |
| Liabilities + Equity | $257M | $262M | $298M | $280M | $335M | $379M | $313M | $332M | $374M | $311M | $359M | $174M | |
| Shares Outstanding | 63,318,613 | 62,819,857 | 62,070,627 | 61,701,467 | 61,307,428 | 56,244,771 | 48,958,763 | 42,353,301 | 36,859,077 | 34,870,607 | 34,345,754 | 27,995,638 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $8M | $10M | $12M | $11M | $12M | $12M | $9M | $7M | $8M | $3M | $2M | |
| Stock-based Comp | $14M | $29M | $18M | $20M | $23M | $21M | $20M | $17M | $15M | $12M | $8M | $3M | |
| Other Non-cash | $-28M | $-38M | $-97M | $496.0K | $24M | $-15M | · | $-7M | $12M | $-5M | $-5M | · | |
| Operating Cash Flow | $-81M | $-68M | $-78M | $-87M | $-144M | $-112M | $-134M | $-153M | $14M | $-44M | $-14M | $-33M | |
| CapEx | $2M | $4M | $2M | $4M | $6M | $6M | $4M | $25M | $29M | $11M | $9M | $4M | |
| Investing Cash Flow | $-114M | $149M | $-80M | $71M | $-37M | $-8M | $-79M | $57M | $78M | · | · | · | |
| Stock Issued | $0 | $0 | $616.0K | $1M | $118M | $170M | $119M | $103M | $34M | $0 | $203M | $77M | |
| Net Stock Activity | $0 | $0 | $616.0K | $1M | $118M | $170M | · | $103M | $34M | $0 | $203M | · | |
| Financing Cash Flow | $70M | $960.0K | $150M | $2M | $123M | $174M | $120M | $105M | $35M | · | · | · | |
| Net Change in Cash | $-126M | $82M | $-8M | $-15M | $-58M | $55M | $-94M | $8M | $128M | $-112M | $39M | $41M | |
| Free Cash Flow | $-83M | $-72M | $-80M | $-91M | $-150M | $-118M | · | $-178M | $-15M | $-55M | $-23M | · | |
| Levered FCF | · | $-73M | · | · | · | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% | -125.0% | · | -284.8% | -14.0% | -65.3% | -20.0% | · | |
| Net Margin | -49.9% | -44.7% | -15.4% | -78.8% | -261.0% | -123.7% | · | -285.2% | -12.4% | -63.7% | -20.0% | · | |
| Pretax Margin | -50.4% | -44.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -43.9% | -68.7% | -270.0% | -72.1% | -247.3% | -113.6% | · | -271.0% | -9.5% | -57.1% | -16.8% | · | |
| ROA | -28.8% | -23.9% | -3.1% | -38.9% | -56.6% | -37.5% | · | -48.6% | -5.7% | -17.5% | -7.6% | · | |
| ROE | -87.0% | -49.9% | -6.2% | -62.8% | -75.5% | -49.3% | · | -63.2% | -6.9% | -20.1% | -9.3% | · | |
| ROIC | -129.9% | -96.6% | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 3.9 | 4.5 | 4.6 | 3.7 | 6.2 | · | 4.5 | 6.5 | 10.4 | 14.7 | · | |
| Quick Ratio | 1.6 | 3.4 | 2.0 | 3.4 | 1.8 | 4.0 | · | 4.4 | 6.4 | 10.2 | 8.5 | · | |
| Interest Coverage | · | -99.2 | -117.7 | · | · | · | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.2 | 0.5 | 0.2 | 0.3 | · | 0.2 | 0.5 | 0.3 | 0.4 | · | |
| Inventory Turnover | 0.0 | 1.4 | 0.5 | 1.1 | 1.2 | · | · | · | · | · | · | · | |
| Receivables Turnover | 16.9 | 20.4 | 1.8 | 4.6 | 4.6 | 5.9 | · | 2.8 | 19.2 | 46.1 | 48.5 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.88 | $1.85 | $2.46 | $2.30 | $3.91 | $5.26 | · | $5.73 | $8.12 | $7.71 | $9.12 | · | |
| Revenue / Share | $2.37 | $2.39 | $0.95 | $2.47 | $1.29 | · | · | · | $4.37 | $2.65 | $3.17 | · | |
| Cash Flow / Share | $-1.28 | $-1.09 | $-1.26 | $-1.42 | $-2.40 | · | · | · | $0.40 | $-1.26 | $-0.43 | · | |
| Cash / Share | $0.90 | $2.91 | $1.63 | $1.76 | $2.01 | $3.22 | · | $5.20 | $5.74 | $2.41 | $5.71 | · | |
| EPS (TTM) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | $-0.70 | $-0.70 | $-0.70 | $-1.73 | $-0.58 | $-1.40 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.31% | 155.3% | -61.3% | 96.2% | -26.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.54% | 24.6% | -17.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.3% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $150M | $150M | $59M | $152M | $77M | $105M | $64M | $60M | $158M | $92M | $101M | $48M | |
| Net Income TTM | $-75M | $-67M | $-9M | $-120M | $-202M | $-130M | $-152M | $-171M | $-20M | $-59M | $-20M | $-38M | |
| Market Cap | $102M | $204M | $597M | $414M | $984M | $1.29B | · | $538M | $700M | $713M | $1.06B | · | |
| P/E | -1.4 | -3.0 | -64.1 | -3.4 | -4.8 | -9.3 | -15.5 | -18.1 | -27.1 | -11.8 | -53.4 | -25.1 | |
| P/S | 0.7 | 1.4 | 10.2 | 2.7 | 12.7 | 12.3 | · | 8.9 | 4.4 | 7.8 | 10.5 | · | |
| P/B | 1.8 | 1.8 | 3.9 | 2.9 | 4.1 | 4.3 | · | 2.2 | 2.3 | 2.7 | 3.4 | · | |
| P / Tangible Book | 1.8 | 1.8 | 3.9 | 2.9 | 4.1 | 4.3 | · | · | · | · | · | · | |
| P / Cash Flow | -1.3 | -3.0 | -7.6 | -4.8 | -6.8 | -11.5 | · | -3.5 | 48.6 | -16.3 | -77.9 | · | |
| P / FCF | -1.2 | -2.8 | -7.5 | -4.6 | -6.6 | -10.9 | · | -3.0 | -46.7 | -12.9 | -46.5 | · | |
| Earnings Yield | -73.3% | -32.9% | -1.6% | -29.1% | -21.0% | -10.8% | -6.4% | -5.5% | -3.7% | -8.5% | -1.9% | -4.0% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $21M | $41M | $73M | $7M | $13M | $19M | $111M | $11M | $9M | $10M | $13M | $24M | $73M | $42M | $26M | |
| Cost of Revenue | · | · | $0 | $0 | $0 | $0 | $233.0K | $168.0K | $176.0K | $270.0K | $85.0K | $258.0K | $113.0K | $116.0K | $3M | $180.0K | |
| R&D Expense | $39M | $35M | $34M | $33M | $41M | $40M | $39M | $41M | $52M | $46M | $30M | $43M | $46M | $46M | $48M | $52M | |
| SG&A Expense | $8M | $10M | $9M | $10M | $9M | $11M | $28M | $14M | $14M | $15M | $12M | $14M | $14M | $14M | $15M | $14M | |
| Operating Expenses | $47M | $54M | $53M | $54M | $50M | $56M | $72M | $57M | $69M | $63M | $46M | $58M | $63M | $61M | $67M | $68M | |
| Operating Income | $-14M | $-33M | $-12M | $19M | $-43M | $-43M | $-53M | $54M | $-58M | $-54M | $-36M | $-45M | $-38M | $12M | $-25M | $-42M | |
| Interest Expense | $4M | $5M | · | $3M | $802.0K | $91.0K | · | $0 | $6.0K | $1M | $0 | $774.0K | $656.0K | $0 | $0 | $0 | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | · | · | $819.0K | $142.0K | $504.0K | |
| Pretax Income | $-70M | · | $-15M | $17M | $-43M | · | $-14M | $56M | $-56M | · | · | · | · | · | · | · | |
| Income Tax | $0 | · | $-777.0K | $0 | $105.0K | · | $944.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $20M | $-37M | $-14M | $17M | $-36M | $-41M | $-15M | $56M | $-56M | $-52M | $18M | $57M | $-38M | $13M | $-25M | $-41M | |
| EPS (Basic) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 | $-0.89 | $-0.84 | $0.28 | $0.93 | $-0.61 | $0.20 | $-0.40 | $-0.67 | |
| EPS (Diluted) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 | $-0.89 | $-0.84 | $0.28 | $0.92 | $-0.61 | $0.20 | $-0.40 | $-0.67 | |
| Shares (Basic) | 63,594,453 | 63,449,780 | · | 63,233,266 | 63,136,057 | 62,965,415 | · | 62,744,005 | 62,663,677 | 62,290,538 | 61,980,680 | 61,880,096 | 61,809,817 | · | 61,459,831 | 61,384,943 | |
| Shares (Diluted) | 63,594,453 | 63,449,780 | · | 63,283,624 | 63,136,057 | 62,965,415 | · | 62,865,841 | 62,663,677 | 62,290,538 | 62,244,602 | 62,261,646 | 61,809,817 | · | 61,459,831 | 61,384,943 | |
| EBITDA | $-14M | $-32M | · | $19M | $-37M | $-41M | · | $54M | $-58M | $-52M | $-36M | $-45M | $-35M | · | $-25M | $-42M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $114M | $67M | $57M | $80M | $131M | $146M | $183M | $180M | $84M | $80M | $90M | $109M | $224M | · | $84M | $21M | |
| Receivables | $25M | $10M | $13M | $69M | $13M | $11M | $4M | $9M | $6M | $7M | $25M | $6M | $36M | · | $14M | $18M | |
| Inventory | · | $9M | $8M | $9M | $9M | $9M | $0 | $3M | $1M | $1M | $1M | $1M | $1M | · | $1M | $3M | |
| Prepaid Expense | $4M | $8M | $9M | $8M | $7M | $8M | $12M | $10M | $9M | $10M | $9M | $6M | $10M | · | $9M | $13M | |
| Current Assets | $322M | $183M | $220M | $232M | $205M | $182M | $217M | $222M | $157M | $203M | $291M | $255M | $289M | · | $148M | $168M | |
| PP&E (Net) | $2M | $11M | $13M | $14M | $15M | $17M | $18M | $19M | $20M | $21M | $23M | $24M | $27M | · | $32M | $34M | |
| PP&E (Gross) | · | · | $108M | · | · | · | $107M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $96M | · | · | · | $89M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $195.0K | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | · | $16M | $16M | |
| Total Assets | $345M | $218M | $257M | $271M | $245M | $225M | $262M | $264M | $201M | $248M | $340M | $306M | $343M | · | $195M | $218M | |
| Accounts Payable | $3M | $4M | $5M | $6M | $5M | $7M | $5M | $7M | $5M | $11M | $3M | $4M | $4M | · | $5M | $3M | |
| Accrued Liabilities | $30M | $18M | $22M | $23M | $21M | $28M | $29M | $25M | $24M | $18M | $25M | $28M | $28M | · | $33M | $32M | |
| Current Liabilities | $109M | $96M | $43M | $44M | $39M | $55M | $56M | $59M | $58M | $56M | $51M | $45M | $46M | · | $50M | $51M | |
| Capital Leases | $30M | $31M | $32M | $32M | $32M | $32M | $33M | $29M | $30M | $30M | $30M | $30M | $30M | · | $17M | $18M | |
| Other Non-current Liabilities | $450.0K | $727.0K | $1M | $1M | $2M | $2M | $2M | $258.0K | $258.0K | $258.0K | $258.0K | $258.0K | $258.0K | · | $258.0K | $258.0K | |
| Total Liabilities | $303M | $197M | $201M | $204M | $199M | $145M | $146M | $144M | $143M | $142M | $146M | $134M | $234M | · | $72M | $76M | |
| Common Stock | $637.0K | $636.0K | $633.0K | $633.0K | $632.0K | $631.0K | $628.0K | $627.0K | $627.0K | $626.0K | $620.0K | $619.0K | $618.0K | · | $615.0K | $615.0K | |
| Retained Earnings | $-1.26B | $-1.28B | $-1.24B | $-1.23B | $-1.25B | $-1.21B | $-1.17B | $-1.15B | $-1.21B | $-1.15B | $-1.06B | $-1.07B | $-1.13B | · | $-1.11B | $-1.08B | |
| Stockholders' Equity | $43M | $21M | $56M | $67M | $47M | $79M | $116M | $120M | $58M | $106M | $194M | $172M | $109M | $142M | $123M | $142M | |
| Liabilities + Equity | $345M | $218M | $257M | $271M | $245M | $225M | $262M | $264M | $201M | $248M | $340M | $306M | $343M | · | $195M | $218M | |
| Shares Outstanding | 63,645,711 | 63,560,068 | 63,318,613 | 63,258,532 | 63,205,703 | 63,090,323 | 62,819,857 | 62,763,120 | 62,720,969 | 62,560,502 | 62,028,904 | 61,938,493 | 61,838,565 | · | 61,462,189 | 61,458,790 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $2M | $3M | $3M | $4M | $4M | $4M | $11M | $6M | $7M | $6M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-3M | · | · | · | $-12M | · | · | · | $-847.0K | · | · | $17M | · | · | · | |
| Operating Cash Flow | $-41M | $-36M | $43M | $-30M | $-47M | $-47M | $-38M | $60M | $-44M | $-46M | $-35M | $-2M | $-13M | $29M | $-9M | $-49M | |
| CapEx | $806.0K | $344.0K | $244.0K | $426.0K | $715.0K | $529.0K | $620.0K | $592.0K | $1M | $1M | $499.0K | $286.0K | $359.0K | $393.0K | $804.0K | $1M | |
| Investing Cash Flow | $28M | $45M | $-66M | $-20M | $-38M | $10M | $41M | $36M | $47M | $25M | $-34M | $-113M | $28M | $-6M | $72M | $23M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $616.0K | $1M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | $616.0K | · | · | · | |
| Financing Cash Flow | $60M | $-207.0K | $57.0K | $0 | $70M | $-282.0K | $155.0K | $-68.0K | $625.0K | $248.0K | $50M | $59.0K | $100M | $1M | $0 | $263.0K | |
| Net Change in Cash | $47M | $9M | $-23M | $-51M | $-15M | $-37M | $3M | $96M | $4M | $-21M | $-19M | $-116M | $115M | $25M | $63M | $-26M | |
| Free Cash Flow | · | $-36M | · | · | · | $-47M | · | · | · | $-47M | · | · | $-13M | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -42.2% | -161.0% | · | 25.6% | -165.3% | -323.1% | · | 48.9% | -538.9% | -590.4% | -341.5% | -342.3% | -156.9% | · | -59.8% | -160.8% | |
| Net Margin | 59.4% | -177.0% | · | 23.1% | -163.0% | -311.1% | · | 50.9% | -515.5% | -573.3% | 168.8% | 437.5% | -155.2% | · | -59.5% | -158.8% | |
| Pretax Margin | -212.1% | · | · | 23.1% | -162.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -42.2% | -152.8% | · | 25.6% | -165.3% | -309.7% | · | 48.9% | -538.9% | -570.2% | -341.5% | -342.3% | -144.7% | · | -59.8% | -160.8% | |
| ROA | 6.6% | -16.6% | · | 6.3% | -16.2% | -17.4% | · | 18.6% | -22.0% | -17.6% | 6.6% | 21.9% | -12.4% | · | -8.5% | -12.8% | |
| ROE | 43.6% | -73.3% | · | 18.0% | -69.4% | -44.3% | · | 35.9% | -48.5% | -48.4% | 11.1% | 36.6% | -26.4% | · | -12.0% | -17.9% | |
| ROIC | -32.3% | · | · | 27.8% | -79.1% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.9 | · | 5.2 | 5.3 | 3.3 | · | 3.7 | 2.7 | 3.6 | 5.7 | 5.6 | 6.3 | · | 3.0 | 3.3 | |
| Quick Ratio | 1.3 | 0.8 | · | 3.4 | 3.7 | 2.8 | · | 3.2 | 1.6 | 1.6 | 2.2 | 2.6 | 5.7 | · | 2.0 | 0.8 | |
| Interest Coverage | -3.2 | -6.8 | · | 5.6 | -45.8 | -468.4 | · | · | -9696.8 | -47.4 | · | -58.1 | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.3 | 0.1 | 0.1 | · | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | · | 1.2 | 0.0 | |
| Receivables Turnover | 1.8 | 2.0 | · | 1.9 | 2.4 | 1.5 | · | 6.5 | 1.7 | 0.4 | 0.5 | 1.1 | 1.0 | · | 3.0 | 0.8 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.67 | $0.33 | · | $1.06 | $0.74 | $1.25 | · | $1.91 | $0.92 | $1.70 | $3.13 | $2.77 | $1.77 | · | $2.00 | $2.32 | |
| Revenue / Share | $0.52 | $0.33 | · | $1.15 | $0.35 | $0.21 | · | $1.76 | $0.17 | $0.15 | $0.17 | $0.21 | $0.40 | · | $0.68 | $0.42 | |
| Cash Flow / Share | · | $-0.56 | · | · | · | $-0.74 | · | · | · | $-0.73 | · | · | $-0.21 | · | · | · | |
| Cash / Share | $1.79 | $1.05 | · | $1.27 | $2.07 | $2.31 | · | $2.86 | $1.34 | $1.28 | $1.45 | $1.76 | $3.63 | · | $1.37 | $0.35 | |
| EPS (TTM) | $-0.23 | $-1.11 | · | $-1.19 | $-0.56 | $-0.88 | · | $-1.57 | $-2.19 | $-0.38 | $0.79 | $0.11 | $-1.48 | · | $-3.10 | $-3.56 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $168M | $142M | · | $112M | $150M | $154M | · | $141M | $41M | $43M | $121M | $152M | $165M | · | $93M | $67M | |
| Net Income TTM | $-15M | $-70M | · | $-76M | $-36M | $-56M | · | $-98M | $-136M | $-23M | $50M | $7M | $-91M | · | $-191M | $-219M | |
| Market Cap | $294M | $184M | · | $106M | $76M | $80M | · | $206M | $267M | $921M | $289M | $331M | $443M | · | $213M | $181M | |
| P/E | -20.1 | -2.6 | · | -1.4 | -2.2 | -1.4 | · | -2.1 | -1.9 | -38.7 | 5.9 | 48.6 | -4.8 | · | -1.1 | -0.8 | |
| P/S | 1.8 | 1.3 | · | 0.9 | 0.5 | 0.5 | · | 1.5 | 6.5 | 21.2 | 2.4 | 2.2 | 2.7 | · | 2.3 | 2.7 | |
| P/B | 6.9 | 8.7 | · | 1.6 | 1.6 | 1.0 | · | 1.7 | 4.6 | 8.7 | 1.5 | 1.9 | 4.1 | · | 1.7 | 1.3 | |
| P / Tangible Book | 6.9 | 8.7 | · | 1.6 | 1.6 | 1.0 | · | 1.7 | 4.6 | 8.7 | 1.5 | 1.9 | 4.1 | · | 1.7 | 1.3 | |
| P / Cash Flow | · | -5.1 | · | · | · | -1.7 | · | · | · | -20.2 | · | · | -34.6 | · | · | · | |
| Earnings Yield | -5.0% | -38.4% | · | -70.8% | -46.3% | -69.3% | · | -47.7% | -51.5% | -2.6% | 17.0% | 2.1% | -20.6% | · | -89.6% | -120.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $150M | $150M | $59M | $152M | $77M |
| Margen Operativo % | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% |
| Beneficio neto | $-75M | $-67M | $-9M | $-120M | $-202M |
| EPS Diluido | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 5.1 | 3.9 | 4.5 | 4.6 | 3.7 |
| Ratio Rápido | 1.6 | 3.4 | 2.0 | 3.4 | 1.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-83M | $-72M | $-80M | $-91M | $-150M |
Propietarios institucionales (13F) 135 declarantes · $217.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
135
Valor en tenencia
$217.6M
Nuevas posiciones
40
Posiciones cerradas
24
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 40 (+4 vs trimestre anterior) | 24 (+15 vs trimestre anterior) | 34 (+5 vs trimestre anterior) | 31 (+3 vs trimestre anterior) | +3.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $23 131 194 | 5 006 752 | 10,63% | Acciones |
| BlackRock, Inc. | $21 618 040 | 4 679 229 | 9,94% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $12 270 766 | 2 656 010 | 5,64% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $12 163 305 | 2 632 750 | 5,59% | Acciones |
| BANK OF AMERICA CORP /DE/ | $11 495 724 | 2 488 252 | 5,28% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $11 391 529 | 2 465 699 | 5,24% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $10 969 248 | 2 374 296 | 5,04% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $8 612 493 | 1 864 176 | 3,96% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 409 467 | 1 820 231 | 3,87% | Acciones |
| MACKENZIE FINANCIAL CORP | $7 588 932 | 1 642 626 | 3,49% | Acciones |
| MARSHALL WACE, LLP | $7 466 936 | 1 616 220 | 3,43% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $7 285 810 | 1 576 549 | 3,35% | Acciones |
| VANGUARD GROUP INC | $6 805 375 | 4 226 941 | 3,13% | Acciones |
| Affinity Asset Advisors, LLC | $5 620 720 | 1 216 606 | 2,58% | Acciones |
| D. E. Shaw & Co., Inc. | $4 911 018 | 1 062 991 | 2,26% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4 630 506 | 1 002 274 | 2,13% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $4 621 903 | 1 000 412 | 2,12% | Acciones |
| WASATCH ADVISORS LP | $4 507 536 | 1 559 701 | 2,07% | Acciones |
| STATE STREET CORP | $3 990 123 | 863 663 | 1,83% | Acciones |
| GOLDMAN SACHS GROUP INC | $2 577 964 | 558 001 | 1,18% | Acciones |
| NORTHERN TRUST CORP | $2 384 516 | 516 129 | 1,10% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 940 890 | 420 106 | 0,89% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 940 000 | 420 000 | 0,89% | Acciones |
| TWO SIGMA ADVISERS, LP | $1 923 950 | 1 195 000 | 0,88% | Acciones |
| Walleye Capital LLC | $1 885 653 | 408 150 | 0,87% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $1 753 576 | 379 335 | 0,81% | Acciones |
| DIADEMA PARTNERS LP | $1 729 742 | 374 403 | 0,80% | Acciones |
| PINNACLE ASSOCIATES LTD | $1 174 871 | 254 301 | 0,54% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $1 155 711 | 250 154 | 0,53% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $889 974 | 192 635 | 0,41% | Acciones |
| Man Group plc | $869 433 | 188 189 | 0,40% | Acciones |
| Amundi | $837 352 | 181 245 | 0,38% | Acciones |
| CITADEL ADVISORS LLC | $830 828 | 179 833 | 0,38% | Acciones |
| Informed Momentum Co LLC | $793 277 | 171 705 | 0,36% | Acciones |
| LPL Financial LLC | $786 615 | 170 263 | 0,36% | Acciones |
| SEI INVESTMENTS CO | $760 932 | 164 704 | 0,35% | Acciones |
| ROYAL BANK OF CANADA | $679 000 | 147 058 | 0,31% | Acciones |
| STRS OHIO | $658 350 | 142 500 | 0,30% | Acciones |
| Bank of New York Mellon Corp | $626 272 | 135 557 | 0,29% | Acciones |
| Nuveen, LLC | $608 698 | 131 753 | 0,28% | Acciones |
| ADAR1 Capital Management, LLC | $599 778 | 129 822 | 0,28% | Acciones |
| Squarepoint Ops LLC | $542 286 | 117 378 | 0,25% | Acciones |
| Invesco Ltd. | $475 790 | 102 985 | 0,22% | Acciones |
| Headlands Technologies LLC | $458 249 | 99 188 | 0,21% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $446 689 | 96 686 | 0,21% | Acciones |
| Persistent Asset Partners Ltd | $440 614 | 95 371 | 0,20% | Acciones |
| MORGAN STANLEY | $428 681 | 92 788 | 0,20% | Acciones |
| JANE STREET GROUP, LLC | $387 442 | 83 862 | 0,18% | Acciones |
| FMR LLC | $386 315 | 83 618 | 0,18% | Acciones |
| XTX Topco Ltd | $351 393 | 76 059 | 0,16% | Acciones |
Informantes de la empresa 27 insiders · 11 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Eric Blasius Risser | President and CEO | 12 de febrero de 2026 A | 77 169 | 0 | 0 | $0 |
| James Karrels | SVP and CFO | 12 de febrero de 2026 A | 206 037 | 0 | 0 | $0 |
| Jeffrey Stuart Peters | Senior VP, GC, and Secretary | 19 de agosto de 2026 S | 0 | 0 | 1 | $-129 086 |
| Ezio Bonvini | Sr VP, Research & CSO | 17 de agosto de 2026 M | 185 799 | 0 | 0 | $0 |
| Beth Ann Smith | VP, Controller & Treasurer | 12 de febrero de 2026 A | 12 781 | 0 | 0 | $0 |
| Thomas Spitznagel | Sr VP, Technical Ops | 12 de febrero de 2026 A | 38 543 | 0 | 0 | $0 |
| Stephen L. Eck | Chief Medical Officer | 15 de febrero de 2025 M | 29 377 | 0 | 0 | $0 |
| Lynn Cilinski | VP, Controller and Treasurer | 15 de febrero de 2024 M | 6 213 | 0 | 0 | $0 |
| Jon Marc Wigginton | Sr VP, Clinical Dev. & CMO | 20 de febrero de 2020 A | 18 930 | 0 | 0 | $0 |
| Kathryn E Stein | SVP, Product Dev. & Regulatory | 7 de enero de 2016 M | 95 555 | 0 | 0 | $0 |
| Stanford John Stewart | V P, Clinical Oncology | 9 de octubre de 2013 A | · | 0 | 0 | $0 |
| Karen Jean Ferrante | Consejero | 19 de mayo de 2026 A | 14 750 | 0 | 0 | $0 |
| Scott Koenig | Consejero | 19 de mayo de 2026 A | 867 240 | 0 | 0 | $0 |
| Scott Thomas Jackson | Consejero | 19 de mayo de 2026 A | 14 750 | 0 | 0 | $0 |
| William K Heiden | Consejero | 19 de mayo de 2026 A | 114 750 | 0 | 0 | $0 |
| Edward Hurwitz | Consejero | 19 de mayo de 2026 A | 47 824 | 0 | 0 | $0 |
| David C Stump | Consejero | 19 de mayo de 2026 A | 14 750 | 0 | 0 | $0 |
| Federica F. O'Brien | Consejero | 19 de mayo de 2026 A | 14 750 | 0 | 0 | $0 |
| Jay Philip Siegel | Consejero | 18 de mayo de 2026 M | 14 750 | 0 | 0 | $0 |
| Meenu Chhabra | Consejero | 18 de mayo de 2026 M | 14 750 | 0 | 0 | $0 |
| Kenneth Galbraith | Consejero | 13 de mayo de 2021 A | 0 | 0 | 0 | $0 |
| Paulo F Costa | Consejero | 13 de mayo de 2021 A | 59 435 | 0 | 0 | $0 |
| Matthew K Fust | Consejero | 16 de mayo de 2019 A | 500 | 0 | 0 | $0 |
| Arnold L Oronsky | Consejero | 18 de febrero de 2014 S | 1 708 716 | 0 | 0 | $0 |
| Eran Nadav | Consejero | 9 de octubre de 2013 A | · | 0 | 0 | $0 |
| Margaret Liu | · | 19 de mayo de 2026 A | 14 750 | 0 | 0 | $0 |
| Atul Saran | · | 28 de abril de 2017 F | 16 986 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 16 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,47% | 30 054 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,06% | 213 537 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,01% | 513 042 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 361 044 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 58 897 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 532 314 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 29 881 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 20 270 SH | 2 de octubre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 65 703 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 958 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 666 535 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 925 510 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7 105 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 334 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 1 871 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 55 530 SH | 11 de septiembre de 2026 | Diario |
MGNX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$8.50
+137,4%
3 21,4%
Compra fuerte
6 42,9%
Compra
5 35,7%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-09-30Objetivo medio $8.00 +123,5%
← Por Debajo de Todos los Objetivos
Precio Actual $3.58
Mín$4.00
Media$8.00
Máx$11.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 14, 2026